AnaptysBio Inc sell JPMorgan Chase & Co.
Start price
13.04.23
/
50%
€19.70
Target price
13.04.24
€28.05
Performance (%)
1.02%
End price
14.04.24
€19.90
Summary
This prediction ended on 14.04.24 with a price of €19.90. The SELL prediction by JPMorgan_Chase___Co_ shows the price for AnaptysBio Inc slightly increased by 1.02% during the runtime of the prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AnaptysBio Inc | -2.164% | -2.164% | 119.815% | 208.312% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % | 53,61 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % | 72,78 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % | 62,43 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % | 60,74 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $31.00. They now have an "underweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten